Department of Emerging Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
J Med Virol. 2021 Oct;93(10):6054-6058. doi: 10.1002/jmv.27164. Epub 2021 Jul 9.
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern with higher infectivity has already resulted in the enormous increase in infection cases worldwide. We report an unrecognized introduction of the variant B.1.1.7 in Gabon in December 2020, which was the initial phase of the variant introduction to Africa. The B.1.1.7 variant was also detected in a hospitalized patient in January 2021, indicating a rapid spread of the variant in Gabon since its first detection. Phylogenetic analysis revealed that the detected B.1.1.7 variants originated from the distinct regions, strongly suggesting that the B.1.1.7 variant had been repeatedly introduced to Gabon since December 2020. These results provide insights on the unrecognized risks of infections with variants of concern, and show the necessity to conduct continuous genomic monitoring for immediate alert and control of novel SARS-CoV-2 variant infections.
高传染性的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株迅速传播,已导致全球感染病例大量增加。我们报告了在 2020 年 12 月加蓬发现一种未被识别的 B.1.1.7 变异株,这是该变异株传入非洲的初始阶段。2021 年 1 月,在一名住院患者中也检测到了 B.1.1.7 变异株,表明自首次检测以来,该变异株在加蓬迅速传播。系统进化分析显示,检测到的 B.1.1.7 变异株源自不同地区,强烈表明自 2020 年 12 月以来,B.1.1.7 变异株已多次传入加蓬。这些结果提供了对关注变异株感染的未被识别风险的深入了解,并表明有必要进行持续的基因组监测,以对新型 SARS-CoV-2 变异株感染发出即时警报和进行控制。